Romain-David Seban - JoVE Visualize

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

Radiology|December 6, 2022

Emerging and Evolving Concepts in Cancer Immunotherapy ImagingLaurent Dercle, Shawn Sun, Romain-David Seban, et al.

Clinical Nuclear Medicine|January 9, 2025

FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer PatientsJeremy McGale, Sakshi Khurana, Harrison Howell, et al.

Iscience|March 19, 2026

CMV seropositivity associates with poor clinical outcome in triple negative breast cancerRomain-David Seban, Constance Lamy, Luc Cabel, et al.

Radiology|April 15, 2020

Performance of CT Compared with 18F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin LymphomaFatima-Zohra Mokrane, Aiping Chen, Lawrence H Schwartz, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2019

Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with NivolumabAiping Chen, Fatima-Zohra Mokrane, Lawrence H Schwartz, et al.

Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

Radiology|December 6, 2022

Emerging and Evolving Concepts in Cancer Immunotherapy ImagingLaurent Dercle, Shawn Sun, Romain-David Seban, et al.

Clinical Nuclear Medicine|January 9, 2025

FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer PatientsJeremy McGale, Sakshi Khurana, Harrison Howell, et al.

Iscience|March 19, 2026

CMV seropositivity associates with poor clinical outcome in triple negative breast cancerRomain-David Seban, Constance Lamy, Luc Cabel, et al.

Radiology|April 15, 2020

Performance of CT Compared with 18F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin LymphomaFatima-Zohra Mokrane, Aiping Chen, Lawrence H Schwartz, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2019

Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with NivolumabAiping Chen, Fatima-Zohra Mokrane, Lawrence H Schwartz, et al.

Pageof 5